Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease

References

• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384
   PubMed Web of Science ®Google Scholar
• Katopodis JN, Kolodny L, Jy W, Horstman LL, De Marchena EJ, Tao JG, Haynes DH, Ahn YS. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384
   PubMedGoogle Scholar
• Blann AD, Nadar SK, Lip GYH. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003; 24: 2166–2179
   PubMed Web of Science ®Google Scholar
• Damodaran SK, Yenamandra SP. On the ethanomedical significance of the Arjun tree, Terminalia arjuna (Roxb) Wight and Arnot. J Ethanopharmacol 1987; 20: 173–190
   PubMedGoogle Scholar
• Kaur K, Arora S, Kumar S, Nagpal A. Antimutagenic activities of acetone and methanol fractions of Terminalia arjuna. Food Chem Toxicol 2002; 40: 1475–1482
   PubMed Web of Science ®Google Scholar
• Ragavan B, Kanya SK. Anti-diabetic effect of T. arjuna bark extract in alloxan induced diabetic rats. Ind J Clin Biochem 2006; 21: 123–128
   PubMedGoogle Scholar
• Dwivedi S. Terminalia arjuna Wight and Arn–a useful drug for cardiovascular disorders. J Ethnopharmacol 2007; 114: 114–129
   PubMed Web of Science ®Google Scholar
• Wahal PK. A preliminary report on the inhibitory effect of abana on platelet aggregation and adhesiveness in cases of coronary heart disease and hypertension. Probe 1991; 30: 312–315
   Google Scholar
• Mary NK, Babu BH, Padikkala J. Antiatherogenic effect of Caps HT2, a herbal Ayurvedic medicine formulation. Phytomedicine 2003; 10: 474–482
   PubMed Web of Science ®Google Scholar
• Gensini GG. A meaningful score in system for determining the severity of Coronary heart disease. Am J Cardiol 1983; 51: 606–607
   PubMed Web of Science ®Google Scholar
• Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Rao HR, Peller JD, White GJ. Measurement of ionized calcium in blood platelets with a new generation calcium indicator. Biochem Biophys Res Commun 1985; 132: 652–657
   PubMed Web of Science ®Google Scholar
• Sivalokanathan S, Vijyababu MR, Balasubramaniam MP. Effects of Terminalia arjuna bark extract on apoptosis of Human hepatoma cell line Hep G2. World J Gastroenterol 2006; 12: 1018–1024
   PubMed Web of Science ®Google Scholar
• Sylviane LT, Maclouf J, Rosa JP, Gallet C, Valles G, Nurden P, Nurden AT. Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets. Thromb Haemost 1998; 80: 463–468
   PubMedGoogle Scholar
• Davies TA, Drotts D, Weil GJ, Simons ER. Flow cytometric measurements of cytoplasmic calcium changes in human platelets. Cytometry Part A 2005; 9: 138–142
   Google Scholar
• Dietrich R, Teresa GP, Debra AP, Ted W, Harold HS, Robert G, Carl LK. Cocoa and Wine polyphenols modulates platelet activation and function. J Nutr 2000; 130: 2120s–2126s
   PubMedGoogle Scholar
• Dwivedi S, Aggarwal A, Aggarwal MP, Rajpal S. Role of Terminalia arjuna in ischemic mitral regurgitation. Int J Cardiol 2005; 12: 391–393
   Google Scholar
• Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug in coronary artery disease. J Assoc Phys Ind 1994; 42: 287–289
   PubMedGoogle Scholar
• Ram A, Lauria P, Gupta R, Kumar R, Sharma VS. Hypocholesterolemic effects of Terminalia arjuna tree bark. J Ethnopharmacol 1997; 55: 165–169
   PubMed Web of Science ®Google Scholar
• Karthikeyan K, Bai BR, Gauthaman K, Sathish KS, Devaraj SN. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo mode of myocardial ischemic reperfusion injury. Life Sci 2003; 73: 2727–2739
   PubMed Web of Science ®Google Scholar
• Bukhtiar SH, Nawaz Z, Saeed SA, Gilani AH. Agonist dependent differential effects of berberine in human platelet aggregation. Phytother Res 1997; 12: S60–S62
   Google Scholar
• Nofer JR, Walter M, Kehrel B, Wierwille S, Tepel M, Seedorf U, Assmann G. HDL-3 mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2 diacylglycerol and inositol 1,4,4 - tris-phosphate. Arterioscler Thromb Vasc Biol 1998; 18: 861–869
   PubMedGoogle Scholar
• Neiva TJ, Morais L, Polack M, Simoes CM, D’Amico EA. Effects of catechins on human blood platelet aggregation and lipid peroxidation. Phytother Res 1999; 13: 597–600
   PubMed Web of Science ®Google Scholar
• Salvemini D, Botting R. Modulation of platelet functions by free radicals and free radical scavengers. Trends Pharmacol Sci 1993; 14: 36–42
   PubMed Web of Science ®Google Scholar
• Kroll MH, Schafer AI. Biochemical mechanism of platelet activation. Blood 1989; 74: 1181
   PubMed Web of Science ®Google Scholar
• Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305
   PubMed Web of Science ®Google Scholar
• Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81–106
   PubMed Web of Science ®Google Scholar
• Aktas B, Pozgajova M, Bergmeier W, Sunnarborg S, Offermanns S, Lee D, Wagner DD, Nieswandt B. Aspirin induces platelet receptor Shedding via ADAM17 (TACE). J Biol Chem 2005; 280: 39716–39722
   PubMed Web of Science ®Google Scholar
• Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP. Molecular Basis for ADP-induced platelet activation. J Biol Chem 1998; 273: 2024–2029
   PubMed Web of Science ®Google Scholar